NUPEC-Nucleo de Pesquisa Clinica

Belo Horizonte 30220-140

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Severe Hypertriglyceridemia

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed